Product Code: CHNL
TABLE OF CONTENTS
List Of Contents And Tables
EXECUTIVE SUMMARY
Consumer health in 2021: The big picture
2021 key trends
Competitive landscape
Retailing developments
What next for consumer health?
MARKET INDICATORS
Table 1 Consumer Expenditure on Health Goods and Medical Services: Value 2016-2021
Table 2 Life Expectancy at Birth 2016-2021
MARKET DATA
Table 3 Sales of Consumer Health by Category: Value 2016-2021
Table 4 Sales of Consumer Health by Category: % Value Growth 2016-2021
Table 5 NBO Company Shares of Consumer Health: % Value 2017-2021
Table 6 LBN Brand Shares of Consumer Health: % Value 2018-2021
Table 7 Penetration of Private Label in Consumer Health by Category: % Value 2016-2021
Table 8 Distribution of Consumer Health by Format: % Value 2016-2021
Table 9 Distribution of Consumer Health by Format and Category: % Value 2021
Table 10 Forecast Sales of Consumer Health by Category: Value 2021-2026
Table 11 Forecast Sales of Consumer Health by Category: % Value Growth 2021-2026
APPENDIX
OTC registration and classification
Vitamins and dietary supplements registration and classification
Self-medication/self-care and preventive medicine
Switches
DISCLAIMER
DEFINITIONS
SOURCES
Summary 1 Research Sources
ANALGESICS IN THE NETHERLANDS
KEY DATA FINDINGS
2021 DEVELOPMENTS
Analgesics struggle as social distancing measures limit number of cases of common cold and flu
GSK Consumer Healthcare maintain its lead
Diclofenac and ibuprofen on downward trend
PROSPECTS AND OPPORTUNITIES
Social behaviour changed by COVID-19
Topical analgesics will be the major driver of growth
Increased shift towards self-care will keep sector buoyant
CATEGORY DATA
Table 12 Sales of Analgesics by Category: Value 2016-2021
Table 13 Sales of Analgesics by Category: % Value Growth 2016-2021
Table 14 NBO Company Shares of Analgesics: % Value 2017-2021
Table 15 LBN Brand Shares of Analgesics: % Value 2018-2021
Table 16 Forecast Sales of Analgesics by Category: Value 2021-2026
Table 17 Forecast Sales of Analgesics by Category: % Value Growth 2021-2026
COUGH, COLD AND ALLERGY (HAY FEVER) REMEDIES IN THE NETHERLANDS
KEY DATA FINDINGS
2021 DEVELOPMENTS
Social distancing measures leads to further decline of cough, cold remedies
Innovations in fast-acting, convenient and non-drowsy products lead competitive developments
COVID-19 increases value growth for antihistamines/allergy remedies
PROSPECTS AND OPPORTUNITIES
Normalisation of public life should help category to recover
Antihistamines/allergy remedies see further growth
Nasal sprays lead value growth
CATEGORY DATA
Table 18 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2016-2021
Table 19 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2016-2021
Table 20 NBO Company Shares of Cough, Cold and Allergy (Hay Fever) Remedies: % Value 2017-2021
Table 21 LBN Brand Shares of Cough, Cold and Allergy (Hay Fever) Remedies: % Value 2018-2021
Table 22 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2021-2026
Table 23 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2021-2026
DIGESTIVE REMEDIES IN THE NETHERLANDS
KEY DATA FINDINGS
2021 DEVELOPMENTS
Second year of decline due to impact of COVID-19
Bayer Consumer Care maintains overall lead, thanks to consumer trust in Rennie brand and innovative Losecosan 20 PPI
E-commerce continues to gain value share
PROSPECTS AND OPPORTUNITIES
Healthy value growth over forecast period
The ageing population will drive strong growth for digestive remedies
Developments in herbal products will lead the way for health-conscious consumers
CATEGORY DATA
Table 24 Sales of Digestive Remedies by Category: Value 2016-2021
Table 25 Sales of Digestive Remedies by Category: % Value Growth 2016-2021
Table 26 NBO Company Shares of Digestive Remedies: % Value 2017-2021
Table 27 LBN Brand Shares of Digestive Remedies: % Value 2018-2021
Table 28 Forecast Sales of Digestive Remedies by Category: Value 2021-2026
Table 29 Forecast Sales of Digestive Remedies by Category: % Value Growth 2021-2026
DERMATOLOGICALS IN THE NETHERLANDS
KEY DATA FINDINGS
2021 DEVELOPMENTS
Frequent hand washing due to COVID-19 boosts value sales
Smaller player Remark wins shares by capitalising on the caterpillar plague with its specialist product
Antiparasitics/Lice (Head and Body) Treatments suffer from social distancing measures
PROSPECTS AND OPPORTUNITIES
Moderate constant value growth over forecast period
Private label pushes for value share
The ageing population of the country continues to support growth across the forecast period
CATEGORY DATA
Table 30 Sales of Dermatologicals by Category: Value 2016-2021
Table 31 Sales of Dermatologicals by Category: % Value Growth 2016-2021
Table 32 NBO Company Shares of Dermatologicals: % Value 2017-2021
Table 33 LBN Brand Shares of Dermatologicals: % Value 2018-2021
Table 34 LBN Brand Shares of Hair Loss Treatments: % Value 2018-2021
Table 35 Forecast Sales of Dermatologicals by Category: Value 2021-2026
Table 36 Forecast Sales of Dermatologicals by Category: % Value Growth 2021-2026
NRT SMOKING CESSATION AIDS IN THE NETHERLANDS
KEY DATA FINDINGS
2021 DEVELOPMENTS
Growth dampened by free access to NRT smoking cessation products from GPs
Traditional NRT product players see stable positions, while Nicorette spray holds dominance in its segment
Negative publicity surrounding vaping leads smokers to consider alternative NRT methods
PROSPECTS AND OPPORTUNITIES
Free access to NRT smoking cessation aids through GPs will hamper value growth
COVID-19 puts health in the spotlight
Other NRT shows high growth potential
CATEGORY INDICATORS
Table 37 Number of Smokers by Gender 2016-2021
CATEGORY DATA
Table 38 Sales of NRT Smoking Cessation Aids by Category: Value 2016-2021
Table 39 Sales of NRT Smoking Cessation Aids by Category: % Value Growth 2016-2021
Table 40 NBO Company Shares of NRT Smoking Cessation Aids: % Value 2017-2021
Table 41 LBN Brand Shares of NRT Smoking Cessation Aids: % Value 2018-2021
Table 42 Forecast Sales of NRT Smoking Cessation Aids by Category: Value 2021-2026
Table 43 Forecast Sales of NRT Smoking Cessation Aids by Category: % Value Growth 2021-2026
SLEEP AIDS IN THE NETHERLANDS
KEY DATA FINDINGS
2021 DEVELOPMENTS
Growth returns to normal patterns
Leader Vemedia faces competition from new entry, as Omega launches Nytol range
E-commerce gains value share
PROSPECTS AND OPPORTUNITIES
Greater acceptance of sleep aids leads to value growth
Return of long-haul international travel boosts sleep aids
Players continue to innovate
CATEGORY DATA
Table 44 Sales of Sleep Aids: Value 2016-2021
Table 45 Sales of Sleep Aids: % Value Growth 2016-2021
Table 46 NBO Company Shares of Sleep Aids: % Value 2017-2021
Table 47 LBN Brand Shares of Sleep Aids: % Value 2018-2021
Table 48 Forecast Sales of Sleep Aids: Value 2021-2026
Table 49 Forecast Sales of Sleep Aids: % Value Growth 2021-2026
EYE CARE IN THE NETHERLANDS
KEY DATA FINDINGS
2021 DEVELOPMENTS
Healthy value sales driven by dry eyes
Natural and specialised eye care products give players a competitive advantage
Allergy eye care receives small boost from COVID-19
PROSPECTS AND OPPORTUNITIES
Outlook very positive over forecast period
Standard eye care set to be boosted by the ageing population
Natural positioning key part of messaging
CATEGORY DATA
Table 50 Sales of Eye Care by Category: Value 2016-2021
Table 51 Sales of Eye Care by Category: % Value Growth 2016-2021
Table 52 NBO Company Shares of Eye Care: % Value 2017-2021
Table 53 LBN Brand Shares of Eye Care: % Value 2018-2021
Table 54 Forecast Sales of Eye Care by Category: Value 2021-2026
Table 55 Forecast Sales of Eye Care by Category: % Value Growth 2021-2026
WOUND CARE IN THE NETHERLANDS
KEY DATA FINDINGS
2021 DEVELOPMENTS
Limited recovery in 2021
Beiersdorf maintains lead, while private label gains over more expensive branded products
Pricing main driver of value sales
PROSPECTS AND OPPORTUNITIES
Recovery picks up as society reopens
First aid kits hampered by weakened distribution
Demographic changes and financial impacts halt possible premiumisation trend, as consumers trade down
CATEGORY DATA
Table 56 Sales of Wound Care by Category: Value 2016-2021
Table 57 Sales of Wound Care by Category: % Value Growth 2016-2021
Table 58 NBO Company Shares of Wound Care: % Value 2017-2021
Table 59 LBN Brand Shares of Wound Care: % Value 2018-2021
Table 60 Forecast Sales of Wound Care by Category: Value 2021-2026
Table 61 Forecast Sales of Wound Care by Category: % Value Growth 2021-2026
VITAMINS IN THE NETHERLANDS
KEY DATA FINDINGS
2021 DEVELOPMENTS
Continued healthy value growth as COVID-19 still lingers
Omega Pharma maintains its lead, but sees growing competition from other players who are aggressive with new launches and promotions
Major players capitalise on boon in vitamins
PROSPECTS AND OPPORTUNITIES
Moderate value growth, though from an elevated level
Private label players can win wider consumer base through building brand trust and offering bulk and economy sales of popular products
Increasing segmentation over forecast period
CATEGORY DATA
Table 62 Sales of Vitamins by Category: Value 2016-2021
Table 63 Sales of Vitamins by Category: % Value Growth 2016-2021
Table 64 Sales of Multivitamins by Positioning: % Value 2016-2021
Table 65 NBO Company Shares of Vitamins: % Value 2017-2021
Table 66 LBN Brand Shares of Vitamins: % Value 2018-2021
Table 67 Forecast Sales of Vitamins by Category: Value 2021-2026
Table 68 Forecast Sales of Vitamins by Category: % Value Growth 2021-2026
DIETARY SUPPLEMENTS IN THE NETHERLANDS
KEY DATA FINDINGS
2021 DEVELOPMENTS
Healthy value growth but lower than 2020
Biohorma maintains lead thanks to high level of consumer trust in A Vogel brand and offering the most in-demand products
VitaePro drives value growth of combination dietary supplements
PROSPECTS AND OPPORTUNITIES
Muted growth over forecast period, after boon caused by COVID-19
Herbal dietary supplements register strong value growth
Bleak outlook for St John's Wort
CATEGORY DATA
Table 69 Sales of Dietary Supplements by Category: Value 2016-2021
Table 70 Sales of Dietary Supplements by Category: % Value Growth 2016-2021
Table 71 Sales of Dietary Supplements by Positioning: % Value 2016-2021
Table 72 NBO Company Shares of Dietary Supplements: % Value 2017-2021
Table 73 LBN Brand Shares of Dietary Supplements: % Value 2018-2021
Table 74 Forecast Sales of Dietary Supplements by Category: Value 2021-2026
Table 75 Forecast Sales of Dietary Supplements by Category: % Value Growth 2021-2026
WEIGHT MANAGEMENT AND WELLBEING IN THE NETHERLANDS
KEY DATA FINDINGS
2021 DEVELOPMENTS
People looking to lose weight gained during lockdown
Herbalife manages to maintain lead, as competition heats up with promotional campaigns and targeted products
Players with online presence perform well
PROSPECTS AND OPPORTUNITIES
Healthy value growth over forecast period
Integrated marketing and promotional activities important to increase brand image and stimulate sales
Slimming teas lose further ground
CATEGORY DATA
Table 76 Sales of Weight Management and Wellbeing by Category: Value 2016-2021
Table 77 Sales of Weight Management and Wellbeing by Category: % Value Growth 2016-2021
Table 78 NBO Company Shares of Weight Management and Wellbeing: % Value 2017-2021
Table 79 LBN Brand Shares of Weight Management and Wellbeing: % Value 2018-2021
Table 80 Forecast Sales of Weight Management and Wellbeing by Category: Value 2021-2026
Table 81 Forecast Sales of Weight Management and Wellbeing by Category: % Value Growth 2021-2026
SPORTS NUTRITION IN THE NETHERLANDS
KEY DATA FINDINGS
2021 DEVELOPMENTS
Recovery begins as gyms start opening up
Body & Fit maintains lead thanks to expanded online distribution, with private label players starting to gain small shares
Players focus on different formulations of products to meet the changing sporting trends
PROSPECTS AND OPPORTUNITIES
Rosy outlook over forecast period
Protein enters the mainstream
E-commerce is key battleground
CATEGORY DATA
Table 82 Sales of Sports Nutrition by Category: Value 2016-2021
Table 83 Sales of Sports Nutrition by Category: % Value Growth 2016-2021
Table 84 NBO Company Shares of Sports Nutrition: % Value 2017-2021
Table 85 LBN Brand Shares of Sports Nutrition: % Value 2018-2021
Table 86 Forecast Sales of Sports Nutrition by Category: Value 2021-2026
Table 87 Forecast Sales of Sports Nutrition by Category: % Value Growth 2021-2026
HERBAL/TRADITIONAL PRODUCTS IN THE NETHERLANDS
KEY DATA FINDINGS
2021 DEVELOPMENTS
Value sales suffer from less prevalence of common cold and flu
Lofthouse of Fleetwood maintains lead with iconic Fisherman's Friend, with new smaller players being tipped as those to watch
Mixed performance in 2021
PROSPECTS AND OPPORTUNITIES
Muted value growth over forecast period
Changes in how people interact dampen value sales of cough and cold remedies
Sleep aids register healthy value growth
CATEGORY DATA
Table 88 Sales of Herbal/Traditional Products by Category: Value 2016-2021
Table 89 Sales of Herbal/Traditional Products by Category: % Value Growth 2016-2021
Table 90 NBO Company Shares of Herbal/Traditional Products: % Value 2017-2021
Table 91 LBN Brand Shares of Herbal/Traditional Products: % Value 2018-2021
Table 92 Forecast Sales of Herbal/Traditional Products by Category: Value 2021-2026
Table 93 Forecast Sales of Herbal/Traditional Products by Category: % Value Growth 2021-2026
PAEDIATRIC CONSUMER HEALTH IN THE NETHERLANDS
KEY DATA FINDINGS
2021 DEVELOPMENTS
Stockpiling early in the pandemic dampens value growth in 2021
Omega maintains lead thanks to strong positioning in paediatric vitamins
Frequent hand washing boon for paediatric dermatologicals
PROSPECTS AND OPPORTUNITIES
Predicted increase in birth rate will drive value sales
Mixed performance for certain products
CATEGORY DATA
Table 94 Sales of Paediatric Consumer Health by Category: Value 2016-2021
Table 95 Sales of Paediatric Consumer Health by Category: % Value Growth 2016-2021
Table 96 Sales of Paediatric Vitamins and Dietary Supplements by Type: % Value 2016-2021
Table 97 NBO Company Shares of Paediatric Consumer Health: % Value 2017-2021
Table 98 LBN Brand Shares of Paediatric Consumer Health: % Value 2018-2021
Table 99 Forecast Sales of Paediatric Consumer Health by Category: Value 2021-2026
Table 100 Forecast Sales of Paediatric Consumer Health by Category: % Value Growth 2021-2026
